glp-1 drugs companies Swiss Re says could reduce US mortality by up to 6.4% Compound versions of GLP-1 drugs

Learn about your first injection, common side effects like nausea, practical tips for managing symptoms, and when to contact your healthcare provider during initial treatment.

In a phase 2 study, amycretin showed a mean weight reduction of up to 24.3%, which is comparable to or even greater than the weight loss seen with tirzepatide and similar to the results for retatrutide

The Medicines and Healthcare products Regulatory Agency (MHRA) has warned healthcare professionals to be aware of the potential risk of pulmonary aspiration in patients using glucagon-like peptide-1 (GLP-1) or dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists (GLP-1 RAs), who undergo surgery or procedures with general anaesthesia or deep sedation

Here is what patients should know.

However, innovations in drug delivery have sparked interest in alternatives like the GLP-1 patch

Here's what to expect and practical steps to help maintain your progress.